The primary endpoint will be the number of CD@ + cells ( cell counts per mm@ ) in bronchial biopsy tissue specimens ( sub-mucosa ) and the key secondary endpoint will be the number of CD@ + cells ( cell counts per mm@ ) , assessed by indirect immunohistochemistry .